Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
PFI-3
i
Other names:
PFI-3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer, Structural Genomics Consortium
Drug class:
SMARCA2 inhibitor, SMARCA4 inhibitor
Related drugs:
‹
FHD-286 (3)
FHD-286 (3)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
Chr t(4;14)
Multiple Myeloma
Chr t(4;14)
Multiple Myeloma
PFI-3
Sensitive: D – Preclinical
PFI-3
Sensitive
:
D
PFI-3
Sensitive: D – Preclinical
PFI-3
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.